INTUITIVE SURGICAL INC Business Intelligence Report
INTUITIVE SURGICAL INC Business Intelligence Report
Quality Scores
Latest Quarterly Earnings Summary
No quarterly summary available yet.
AI Summary
Intuitive Surgical (ISRG) demonstrates exceptional dominance in the robotic-assisted surgery market, maintaining a near-monopoly position with its Da Vinci and Ion platforms. The company's financial profile is characterized by a high-margin recurring revenue model, where instruments and services now outweigh system sales. Over the last decade, ISRG has scaled its revenue from $1.05B to over $10B, maintaining a pristine debt-free balance sheet. The business model benefits from massive network effects and high switching costs as surgeon training becomes standardized on their hardware. Recent…
Key Changes in FY2026
The company has successfully transitioned from a capital equipment manufacturer to a healthcare platform specializing in recurring revenue. Over the last decade, the business mix has shifted heavily toward 'Instruments and Accessories' and services, which now represent the majority of total revenue. Strategic evolution saw the launch of the Ion endoluminal system for lung biopsy and the incremental rollout of the da Vinci 5, which incorporates advanced sensing and AI integration. Geographically, ISRG has moved from US-centricity to a global powerhouse with massive growth in Asian and European surgical volumes. Digital transformation is evident through the Intuitive Hub and data-driven surgical analytics, moving the company up the value chain from hardware to robotic-assisted ecosystems.…
Management Commentary
Under the leadership of Gary Guthart, management has displayed remarkable strategic clarity and visionary long-term planning. Communications are transparent, focusing on clinical outcomes and procedure growth rather than short-term financial engineering. The leadership team successfully navigated the pandemic-driven elective surgery slowdown with proactive cost management and continued R&D investment. Executive incentives appear well-aligned with long-term shareholder interests, focusing on platform adoption and operational excellence. Management has successfully expanded the company's geographic footprint and clinical indications (urology, gynecology, general surgery). Their ability to maintain a technological lead for two decades against well-funded competitors like Medtronic is a…
Financial Highlights
The company's financial evolution shows a transition from a mid-cap medical device player to a large-cap healthcare powerhouse. Revenue has expanded at a multi-year CAGR exceeding 25%, significantly outpacing the broader healthcare sector. Profitability metrics remain robust, with Net Income growing from $204M in 2016 to projected $2.86B by 2025. Operating margins consistently reflect high pricing power despite increasing R&D investments. The asset base has tripled over the period, fueled entirely by internal accruals rather than dilution or debt. Equity growth from $5.78B to $17.82B highlights efficient capital compounding without external reliance.
Major Opportunities
- Zero long-term debt and clean balance sheet
- Massive installed base of over 8,000 systems
- Recurring revenue (instruments/services) > 75% of total
Major Risks
- Heavy reliance on elective surgery volumes
- Intensifying competition from Medtronic and J&J
- High concentration in specialized robotic surgery
About INTUITIVE SURGICAL INC's Annual Report & Financial Performance
The latest INTUITIVE SURGICAL INC annual report (FY2026) is the company's flagship annual disclosure, filed with SEC EDGAR. It covers the full-year business review, management discussion & analysis, audited financial statements, the director's report, the corporate governance and auditor's reports, risk factors, capital allocation, subsidiaries, related-party transactions and ESG initiatives. This Business Intelligence Hub consolidates the official filings with AI-generated financial analysis so investors can see how revenue, operating margin, cash flow quality, capex, dividends, net debt and management outlook have changed — without reading the entire filing.
What this INTUITIVE SURGICAL INC research covers
- Fundamental & business analysis
- Financial statements & performance
- Management commentary & discussion
- Corporate governance & auditor report
- Cash flow analysis & capital allocation
- Valuation analysis & business quality
- Growth analysis & competitive position
- Risk, SWOT & moat analysis
- Quarterly earnings & conference-call summary
- Sector, industry & peer comparison
- Latest official company filings
- Business outlook & long-term growth
INTUITIVE SURGICAL INC — Frequently Asked Questions
Explore more INTUITIVE SURGICAL INC research
AI Top Insights — Premium
Unlock deeper AI Top Insights, advanced comparisons, downloadable reports and premium features.